Literature DB >> 27110696

Prevalence, distribution and risk of sessile serrated adenomas/polyps at a center with a high adenoma detection rate and experienced pathologists.

Joep E G IJspeert1, Koos de Wit1, Manon van der Vlugt1, Barbara A J Bastiaansen1, Paul Fockens1, Evelien Dekker1.   

Abstract

BACKGROUND AND STUDY AIMS: Sessile serrated adenomas/polyps (SSA/Ps) are the precursors of 15 % - 30 % of colorectal cancers (CRC). We aimed to determine the prevalence and distribution of SSA/Ps and to evaluate the association between SSA/Ps and the risk of synchronous advanced neoplasia at a high quality colonoscopy center.
METHODS: Data from all colonoscopies performed within one dedicated colonoscopy center between 2011 and 2015 were prospectively retrieved using an automated reporting system. All lesions were assessed by an experienced gastrointestinal pathologist. Multiple logistic regression was used to evaluate influence of age, gender, and colonoscopy indication on prevalence of SSA/Ps, and to assess the association between SSA/Ps and synchronous advanced neoplasia.
RESULTS: In total 4251 histologically confirmed polyps were resected in 3364 patients; 399 polyps were SSA/Ps (9.4 %). The prevalence of SSA/Ps was 8.2 % overall, increasing to 9.0 % for individuals older than 50 years. SSA/P detection rate varied between 2.5 % and 13.6 % among endoscopists. Increased SSA/P prevalence was associated with colonoscopy indications "familial CRC risk" (odds ratio [OR] 1.52, 95 % confidence interval [95 %CI] 1.05 - 2.22; P = 0.03) and "surveillance" (OR 1.73, 95 %CI 1.20 - 2.49; P < 0.01), when compared with the indication "symptoms." The presence of synchronous advanced neoplasia was associated with SSA/Ps overall (OR 1.71, 95 %CI 1.25 - 2.34; P = 0.001), as well as with high risk SSA/Ps (defined as ≥ 10 mm and/or with dysplasia) (OR 2.70, 95 %CI 1.56 - 4.67; P < 0.001)
CONCLUSION: SSA/Ps are more common than previously reported and are associated with the presence of synchronous advanced neoplasia. Endoscopists should be assiduous in identifying SSA/Ps in daily practice and should carefully look for synchronous advanced neoplasia when an SSA/P has been recognized. RESULTS from this study can guide detection standards in general colonoscopy practice adapted to the type of patient that may predominate in an individual department. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2016        PMID: 27110696     DOI: 10.1055/s-0042-105436

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  25 in total

1.  Sessile Serrated Polyps and Colorectal Cancer.

Authors:  Seth D Crockett
Journal:  JAMA       Date:  2017-03-07       Impact factor: 56.272

2.  Low Sensitivity of Fecal Immunochemical Tests (FIT) for Detection of Sessile Serrated Adenomas/Polyps Confirmed Over Clinical Setting, Geography, and FIT System.

Authors:  Craig Mowat; Jayne Digby; Judith A Strachan; Robert J C Steele; Callum G Fraser
Journal:  Dig Dis Sci       Date:  2019-05-18       Impact factor: 3.199

3.  Comparison of Small Versus Large Volume Split Dose Preparation for Colonoscopy: A Study of Colonoscopy Outcomes.

Authors:  Hassan Siddiki; Sreya Ravi; Mohanad T Al-Qaisi; Ayman R Fath; Francisco Ramirez; Michael D Crowell; Rahul Pannala; Douglas O Faigel; Suryakanth R Gurudu
Journal:  Dig Dis Sci       Date:  2018-05-07       Impact factor: 3.199

4.  Clear colonoscopy as a surveillance tool in the prediction and reduction of advanced neoplasms: a randomized controlled trial.

Authors:  Qisheng Zhang; Yucui Shen; Jianhua Xu; Peng Gao
Journal:  Surg Endosc       Date:  2020-09-09       Impact factor: 4.584

5.  Detection rate and proximal shift tendency of adenomas and serrated polyps: a retrospective study of 62,560 colonoscopies.

Authors:  Shuling Chen; Kaiyu Sun; Kang Chao; Yuli Sun; Liru Hong; Zijin Weng; Yi Cui; Minhu Chen; Shenghong Zhang
Journal:  Int J Colorectal Dis       Date:  2017-12-27       Impact factor: 2.571

6.  Endoscopist factors that influence serrated polyp detection: a multicenter study.

Authors:  Seth D Crockett; Rebecca A Gourevitch; Michele Morris; David S Carrell; Sherri Rose; Zhuo Shi; Julia B Greer; Robert E Schoen; Ateev Mehrotra
Journal:  Endoscopy       Date:  2018-04-24       Impact factor: 10.093

Review 7.  Management of Serrated Polyps of the Colon.

Authors:  Claire Fan; Adam Younis; Christine E Bookhout; Seth D Crockett
Journal:  Curr Treat Options Gastroenterol       Date:  2018-03

Review 8.  Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer.

Authors:  Douglas K Rex; C Richard Boland; Jason A Dominitz; Francis M Giardiello; David A Johnson; Tonya Kaltenbach; Theodore R Levin; David Lieberman; Douglas J Robertson
Journal:  Am J Gastroenterol       Date:  2017-06-06       Impact factor: 10.864

9.  Polyp Detection Rate as a Surrogate for Adenoma and Sessile Serrated Adenoma/Polyp Detection Rates.

Authors:  Leonardo Zorron Cheng Tao Pu; Gurfarmaan Singh; Khizar Rana; Masanao Nakamura; Takeshi Yamamura; Sudarshan Krishnamurthi; Amanda Ovenden; Suzanne Edwards; Andrew Ruszkiewicz; Yoshiki Hirooka; Mitsuhiro Fujishiro; Alastair D Burt; Rajvinder Singh
Journal:  Gastrointest Tumors       Date:  2020-02-11

10.  Difference in Physician- and Patient-Dependent Factors Contributing to Adenoma Detection Rate and Serrated Polyp Detection Rate.

Authors:  Maryan Cavicchi; Gaëlle Tharsis; Pascal Burtin; Philippe Cattan; Franck Venezia; Gilles Tordjman; Agnès Gillet; Joëlle Samama; Karine Nahon-Uzan; David Karsenti
Journal:  Dig Dis Sci       Date:  2019-08-30       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.